Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19
- Conditions
- OximetryCovid19
- Registration Number
- NCT04587921
- Lead Sponsor
- University of Sao Paulo General Hospital
- Brief Summary
The objective of MoxiCov is to monitor the oximetry of patients admitted to the Covid nursery to provide a more detailed assistance expecting to reduce the amount of hypoxia in these patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 90
- Over 18 years old
- COVID 19 positive or suspected COVID19
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Feasibility of the system: Determination of the number of valid versus not valid or missed measurements 6 months Determination of the number of valid versus not valid or missed measurements of each participant.
Hypoxic burden 6 months Time spent with SpO2\< 93%, 90% and 85%
Satisfaction of the nursing, medical team and patients with the implemented system 6 months Measurement of NET PROMOTING SCORE (NPS). This score will show the satisfaction of the healthcare team with the device. This score have a minimum of 0 points and maximum of 32 points.
Hypoxic alarm 6 months Number of times the oximeter record 3 consecutive measurements of SpO2\<90%
- Secondary Outcome Measures
Name Time Method Number of false alarms caused by malfunctions or bad oximeter positioning 6 months Total hospital stay 6 months Time of supplementary oxygen use 6 months Mortality of participants 6 months Time of SpO2<90%, SpO2<85% and SpO2<80% 6 months
Trial Locations
- Locations (1)
Fundação Zerbini - Instituto do Coração (InCor)
🇧🇷São Paulo, SP, Brazil
Fundação Zerbini - Instituto do Coração (InCor)🇧🇷São Paulo, SP, BrazilDiego Prieto, MscContact55 11 2661-5486diego.campos.prieto@gmail.comDaniel Queiróz, PhDContact55 11 2661-5486daniel.bc.queiroz@gmail.comGeraldo Lorenzi, M.D. PhDPrincipal InvestigatorLuciano Drager, M.D. PhDSub InvestigatorPedro Genta, M.D PhDSub Investigator